Protein–ligand (un)binding kinetics as a new paradigm for drug discovery at the crossroad between experiments and modelling
Authors:
- 30 January 2017
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in MedChemComm
- Vol. 8 (3) , 534-550
Abstract
In the last three decades, protein and nucleic acid structure determination and comprehension of the mechanisms, leading to their physiological and pathological functions, have become a cornerstone of biomedical sciences. A deep understanding of the principles governing the fates of cells and tissue at the molecular level has been gained over the years, offering a solid basis for the rational design of drugs aimed at the pharmacological treatment of numerous diseases. Historically, affinity indicators (i.e. Kd and IC50/EC50) have been assumed to be valid indicators of the in vivo efficacy of a drug. However, recent studies pointed out that the kinetics of the drug–receptor binding process could be as important or even more important than affinity in determining the drug efficacy. This eventually led to a growing interest in the characterisation and prediction of the rate constants of protein–ligand association and dissociation. For instance, a drug with a longer residence time can kinetically select a given receptor over another, even if the affinity for both receptors is comparable, thus increasing its therapeutic index. Therefore, understanding the molecular features underlying binding and unbinding processes is of central interest towards the rational control of drug binding kinetics. In this review, we report the theoretical framework behind protein–ligand association and highlight the latest advances in the experimental and computational approaches exploited to investigate the binding kinetics.Keywords
This publication has 144 references indexed in Scilit:
- Population Based Reweighting of Scaled Molecular DynamicsThe Journal of Physical Chemistry B, 2013
- Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug DesignJournal of Medicinal Chemistry, 2012
- Cysteine Mapping in Conformationally Distinct Kinase Nucleotide Binding Sites: Application to the Design of Selective Covalent InhibitorsJournal of Medicinal Chemistry, 2011
- Mechanisms of Protein-Ligand Association and Its Modulation by Protein MutationsBiophysical Journal, 2011
- Drug–target residence time: critical information for lead optimizationCurrent Opinion in Chemical Biology, 2010
- Surface plasmon resonance for high‐throughput ligand screening of membrane‐bound proteinsBiotechnology Journal, 2009
- The role of dynamic conformational ensembles in biomolecular recognitionNature Chemical Biology, 2009
- A partial nudged elastic band implementation for use with large or explicitly solvated systemsInternational Journal of Quantum Chemistry, 2009
- Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand–receptor complexesTrends in Pharmacological Sciences, 2007
- Global and societal implications of the diabetes epidemicNature, 2001